# Orthofix Medical Inc. Common Stock (DE) (OFIX) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Technology. Price $9.29, market value $376 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Orthofix Medical Inc. Common Stock (DE) reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.85**. A PEG of 0.85 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.5×**. Each dollar of revenue is priced at 0.5×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.9×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 33.0×**. Enterprise value is 33.0× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: -7.4%** (5-yr avg -6.2%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 71.3%**. Orthofix Medical Inc. Common Stock (DE) keeps 71.3% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: -4.7%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -11.2%**. The company reported a net loss over the last twelve months.
- **Return on equity: -20.5%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -5.9%**. Return on all capital, debt included, is -5.9%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -7.3%**. Each dollar of assets produces -7.3% of profit.

## Growth
- **Revenue growth (1 yr): 2.9%** (3-yr 21.3%/yr, 5-yr 15.1%/yr). Revenue grew 2.9% over the last year, against 15.1% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 29.4%**. Earnings per share rose 29.4%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.35**. Debt is 0.35 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 5.5×**. It would take 5.5 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Altman Z-score: 1.95**. A Z-score of 1.95 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Orthofix Medical Inc. Common Stock (DE) does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (4 analysts). 4 analysts cover Orthofix Medical Inc. Common Stock (DE); the consensus is buy, with an average price target of $13.00 (+40% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -36.8%** (YTD -38.7%, 3-mo -9.7%). The shares are down 36.8% over twelve months including dividends.
- **From 52-week high: -45.3%** (5.0% above the low). Trading 45% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 35**. An RSI of 35 is neutral.
- **Beta (1 yr): 0.68** (volatility 47%). Beta of 0.68 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OFIX · Page: https://foliofundamentals.com/stocks/ofix

Not investment advice.